Patients (n = 35) | Control (n = 40) | p | |
---|---|---|---|
Age (years) | 32.29 ± 13.41 (18–65) | 34.48 ± 12.98 (18–70) | 0.47 |
Sex | |||
Female | 20 (57.1%) | 23 (57.5%) | 0.98 |
Male | 15 (42.9%) | 17 (42.5%) | |
CRP (mg/dl) | 6.46 ± 4.9 | 5.28 ± 3.49 | 0.31 |
ESR (mm/h) | 28.43 ± 18.47 | 17.73 ± 5.19 | 0.017* |
Neutrophil 1 (103/mL) | 82.01 ± 13.64 | 37.55 ± 11.39 | < 0.001* |
Neutrophil 2 (103/mL) | 36.96 ± 10.62 | 0.82 | |
Lymphocyte 1(103/mL) | 22.59 ± 7.5 | 15.31 ± 5.34 | < 0.001* |
Lymphocytes 2(103/mL) | 16.83 ± 3.83 | 0.17 | |
NLR 1 | 3.95 ± 1.34 | 2.58 ± 0.85 | < 0.001* |
NLR 2 | 2.27 ± 0.76 | 0.10 | |
Hughes disability scale score 1 | 3.28 ± 1.29 | – | |
Hughes disability scale score 2 | 1.92 ± 1.77 | – | |
History of infection: | |||
Yes | 20 (57.1%) | – | |
No | 15 (42.9%) | – |